Labshake search
Citations for Tocris :
401 - 450 of 2755 citations for 6 Isoquinolinol 1 4 5 dimethoxy 2 5 6 6a 7 tetrahydro 1 2 10 trimethoxy 6 methyl 4H dibenzo de g quinolin 9 yl oxy phenyl methyl 1 2 3 4 tetrahydro 7 methoxy 2 methyl S R* R* 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... 2-APB (Tocris, Bio-Techne Corporation), Ryanodine (Tocris) ...
-
bioRxiv - Cell Biology 2020Quote: ... MLi-2 was obtained from Tocris Biosciences (Cat no 5756 ...
-
bioRxiv - Molecular Biology 2019Quote: ... 2-Thio-UTP (Cat # 3280, Tocris); Histamine (Cat # AAJ6172703 ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 2 μM IWP2 (3533, Tocris) to suppress spontaneous differentiation ...
-
bioRxiv - Neuroscience 2021Quote: ... calmidazolium chloride (CMZ, 2 µM, Tocris); methyl arachidonyl fluorophosphonate (MAFP ...
-
bioRxiv - Neuroscience 2020Quote: ... BAM8-22 (2 μM; Tocris, #1763) and NPFF (5 μM ...
-
bioRxiv - Cell Biology 2019Quote: ... and A83-01 (2 μM; Tocris) in E6 medium for 6 days ...
-
bioRxiv - Immunology 2021Quote: ... or BAM8-22 (2 μM; Tocris), then capsaicin (1 μM ...
-
bioRxiv - Pathology 2021Quote: ... and prostacyclin (PGI2; 2 μM, Tocris) followed by resuspension of the platelet pellet in modified Tyrode’s HEPES buffer (134 mmol/L NaCl ...
-
bioRxiv - Developmental Biology 2021Quote: ... Notch inhibitor (DAPT, 2 μM, Tocris), NF-κB inhibitor (JSH-23 ...
-
bioRxiv - Cell Biology 2022Quote: ... 2 μM ZM447439 (AURKB inhibitor, TOCRIS) or the DMSO solvent as control ...
-
bioRxiv - Cell Biology 2022Quote: ... 2 μM tautomycetin (PP1 inhibitor, TOCRIS), 2 μM ZM447439 (AURKB inhibitor ...
-
bioRxiv - Immunology 2023Quote: ... and 2 μM CHIR99021 (Tocris, 4423). Cells were incubated for two days ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 5µM IWP-2 (Tocris), was then exchanged ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2 μM cyclopamine (Tocris, 1623). On day 7 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2 μM A83-01 (Tocris Bioscience), 0.5 mM PGE2 (Tocris).
-
bioRxiv - Developmental Biology 2023Quote: ... and XAV939 (2 μM, Tocris, 3748), respectively ...
-
bioRxiv - Neuroscience 2023Quote: ... MLi-2 (Tocris; Catalog number: 5756), for 72 hours ...
-
bioRxiv - Microbiology 2023Quote: ... 2 µM CHIR99021 (Tocris Bioscience 4423), 5 µM A83-01 (Tocris Bioscience 2939) ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 2 µM CHIR99021 (Tocris Bioscience). Cells were incubated at 37°C in 5% CO2 and 3-20% O2 ...
-
bioRxiv - Genomics 2024Quote: ... supplemented with 7.5μM IWP-2 (Tocris). On D5 ...
-
bioRxiv - Cancer Biology 2020Quote: ... 6-Bnz-cAMP was purchased from Tocris Bioscience (5255) ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-OHDA(100 mg/kg, Tocris, UK) was given every 2 d ...
-
bioRxiv - Cell Biology 2022Quote: ... 6 µM or 20 µM proTAME (Tocris) or 2 µM UMK57 or UMK95 during imaging ...
-
bioRxiv - Cell Biology 2023Quote: ... RAC1 inhibitor (CAS1177865-17-6; Tocris Biosciences) was used at 100 µM ...
-
bioRxiv - Bioengineering 2022Quote: ... and Nodal/Activin inhibitor (SB431542, Tocris, 1614, 5 µM, days 1-10). On day 2 ...
-
bioRxiv - Neuroscience 2024Quote: ... doxycycline (2 µg/mL) and 10 µM Y-27632 (DIV0 only; Tocris) which was exchanged daily ...
-
bioRxiv - Cell Biology 2023Quote: ... The indicated drugs were directly added in the culture medium: torin-1 (10 μM) (4247/10, R&D and Tocris), Rotenone (500 nM ...
-
bioRxiv - Neuroscience 2021Quote: ... and 4-AP (1 mM, Tocris Bioscience), as was done previously (Carta et al. ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 µM 4-OH-TMX (Tocris Bioscience) was added to sustain knockout efficiency ...
-
bioRxiv - Microbiology 2019Quote: ... Z-VAD-fmk (50 μM; R&D) or MCC950 (5 μM; Tocris Bioscience), were added to cells 1 hour prior to infection ...
-
bioRxiv - Neuroscience 2021Quote: ... Eye movements were prevented by injection of a-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Neuroscience 2021Quote: ... Eye movements were prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Neuroscience 2019Quote: ... Eye movements were prevented by injection of a-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye ...
-
bioRxiv - Neuroscience 2020Quote: ... Eye movements were prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Biochemistry 2021Quote: ... cells were treated with either DMSO or 1 µM of LRRK2 kinase inhibitor (MLi-2, cat.no. 5756, TOCRIS) for 90 mins and then examined for localization ...
-
bioRxiv - Neuroscience 2022Quote: ... injected with saline (control) or a range of doses (0.3, 1, 3, or 10mg/kg) of (R)-CPP (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 1μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 3μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Neuroscience 2022Quote: ... Animals were subsequently transferred to 1.5mL Lo-Bind tube and treated with 6-hydroxydopamine (6-OHDA; Tocris, Bristol, UK) containing 2mM ascorbic acid for one-hour ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2021Quote: ... Four of the rats were also infused with 2 μL of either physiological saline or 5 μg/μL yohimbine (Tocris) with a flow rate of 0.5 μL/min as previously reported (Caetano et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... QX-314 (Cat No. 1014); and D-2-amino-5-phosphonovalerate (D-AP5; Cat No. 0106) were purchased from Tocris.
-
A Bidirectional Switch in the Shank3 Phosphorylation State Biases Synapses toward Up or Down ScalingbioRxiv - Neuroscience 2021Quote: ... 6 hrs (Figure 6 – figure supplement 2) or 24 hrs after transfection (the remaining experiments) neurons were treated with tetrodotoxin (TTX, 5 µM, Tocris) for ∼16 hours ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... supplemented with 100 ng/mL Activin A (R&D, Minneapolis, MN, USA) and 3–5 µM CHIR99021 (Tocris Bioscience, Bristol, UK) (differentiation day 0 ...
-
bioRxiv - Neuroscience 2020Quote: ... to isolate inner retinal signaling (B-waves) and DL-2-Amino-4-phosphonobutyric acid (DL-AP4, 40µM, Tocris Bioscience, Bristol, U.K.) to isolate the photoreceptor component of the ERG signal (A-wave) ...
-
bioRxiv - Developmental Biology 2019Quote: ... From day 2 to day 4 the medium was additionally supplemented with BMP and TGFβ inhibitors (Noggin, Peprotech and SB431542, Tocris Bioscience). Treatment with MEK inhibitor (PD184352 ...
-
bioRxiv - Neuroscience 2023Quote: ... in combination with potassium channel blocker 4-aminopyridine (4-AP, 1 mM, Tocris) to facilitate transmitter release at monosynaptic connections from RSC to ChC and recorded the PSP amplitudes (Figure 1H) ...
-
bioRxiv - Cancer Biology 2019Quote: ... The CHEK1/2 inhibitor AZD7762 (Selleckchem, Houston, TX) and the NUAK1/2 inhibitor WZ4003 (Tocris Bioscience, Minneapolis, MN) were applied at 8 different concentrations between 10 µM and 4.6 nM (3-fold dilution steps ...